Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington’s disease patientsEdward J. Wild, Andreas Weiss|Journal of Clinical Investigation|2015Cited by 270
Discovery, Preclinical Characterization, and Early Clinical Activity of JDQ443, a Structurally Novel, Potent, and Selective Covalent Oral Inhibitor of KRASG12CAndreas Weiss, Saskia M. Brachmann, Jeffrey D. Kearns et al.|Cancer Discovery|2022Cited by 134
Calpain-mediated ataxin-3 cleavage in the molecular pathogenesis of spinocerebellar ataxia type 3 (SCA3)Jeannette Hübener‐Schmid, Huu Phuc Nguyen, Jonasz Jeremiasz Weber et al.|Human Molecular Genetics|2012Cited by 78
Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD ratLaura E. Clemens, Huu Phuc Nguyen, Jonasz Jeremiasz Weber et al.|Brain|2015Cited by 42
Inducible mutant huntingtin expression in HN10 cells reproduces Huntington's disease-like neuronal dysfunctionAndreas Weiss, Paolo Paganetti|Molecular Neurodegeneration|2009Cited by 34